When your child starts missing milestones—or even loses abilities they once had—it’s heartbreaking. But when the eventual diagnosis is a rare disease you’ve never heard of, the journey becomes even more complicated.
In this episode of Tiny Expeditions, we explore Rett syndrome, a rare genetic disorder that profoundly impacts communication, movement, and daily life. Affecting mostly girls, Rett syndrome can feel like a mystery, making the path to diagnosis and treatment complex for families.
We sit down with a devoted father whose daughter lives with Rett syndrome. He shares his family’s emotional journey, from the moment they received the diagnosis to how he transformed their heartbreak into hope. We also speak with a patient advocate who shares how her work is helping families find community, support, and hope.
Join us for Tiny Expeditions Season 6, Episode 3, “Turning Pain Into Purpose: Advocating for Families with Rett Syndrome,” as we learn what it means to navigate a rare genetic diagnosis and discover how advocacy and scientific research are helping bring light and support to families facing Rett syndrome.
Behind the Scenes
Meet Our Guests
In this episode, we spoke with Victor Vega, a father whose daughter was diagnosed with Rett syndrome, a life-altering condition rooted in a single gene mutation. What began as a confusing array of developmental signs turned into a mission: to support his daughter and shine a light on Rett syndrome to help other families find hope, resources, and a voice in the rare disease community.
We also talked with Jesse Klein, a parent advocate who has become a patient advocate. She works for Acadia Pharmaceuticals, a pharmaceutical company that focuses on developing treatments for neurological disorders for which no treatments exist, including Rett syndrome, Parkinson’s and Alzheimer’s disease psychoses, and Prader-Willi syndrome.
When One Gene Changes Everything
Most babies with Rett syndrome seem to develop typically at first—smiling, cooing, sitting up—but then something shifts. Skills stall or begin to disappear altogether. Walking, talking, and even purposeful hand movement can fade. These subtle but deeply concerning red flags are often the early signs of many neurodevelopmental disorders.
Rett syndrome is a rare genetic disorder affecting about 9,000 individuals in the US. It affects brain development and impacts just about everything, from communication to movement. Rett syndrome is caused by a spontaneous mutation in a gene called MECP2, which is located on the X chromosome and plays a critical role in brain development. Rather than controlling just one function, MECP2 affects how other genes turn on and off. When something goes wrong in this gene, the effects ripple outward, impacting breathing, mobility, speech, digestion, and more.
To date, researchers have identified over 800 variants in MECP2 that can lead to Rett syndrome. Most of these occur as de novo mutations, meaning they arise spontaneously and are not inherited from a parent. That makes diagnosis complicated, especially when symptoms resemble other conditions like autism or cerebral palsy. But with improved genetic testing, doctors are better equipped to make definitive diagnoses faster, enabling earlier intervention and support.
Tiana’s Story: Finding Answers Through Genomic Research
Victor Vega and his wife were not new to parenting when their second-born, Tiana, began falling behind on developmental milestones, but it didn’t make it any easier. Tiana would miss milestones and then meet them later, leaving her parents on an emotional rollercoaster. Finally, when Tiana was about 14 months old, the Vega’s admitted that there was likely something going on developmentally with Tiana.
Like many parents facing the unknown, Victor and his wife searched for answers through doctor visits, early intervention programs, and developmental specialists. But no one could give them a clear explanation. The more time passed, the more isolated and overwhelmed they felt.
That changed when Tiana enrolled in SouthSeq, a research study based at HudsonAlpha as part of the national CSER (Clinical Sequencing Evidence-Generating Research) project. Through whole genome sequencing, researchers identified a mutation in Tiana’s MECP2 gene, definitively diagnosing Rett syndrome.
While the news was life-changing, the clarity it offered allowed Victor and his family to move forward with a new sense of purpose. With a diagnosis in hand, they could connect with specialists, explore educational and therapeutic services tailored to Rett, and join a larger community of families facing similar challenges.
Tiana’s story is all too familiar for families grappling with rare and undiagnosed conditions. But her journey shows how powerful genomic research can be, not just in diagnosing disorders but also in offering families the answers they need to move forward with understanding, connection, and hope.
How Advocacy Drives Progress
Jesse discussed her role in patient advocacy, emphasizing the importance of accurate diagnosis, community support, and accessible, educational resources for families affected by rare diseases. Patient advocacy goes far beyond raising awareness. It’s about empowering families with the tools they need to make informed decisions, promoting dialogue between scientists, healthcare providers, and families, and working to ensure new therapies are developed with patients’ real needs in mind.
When a rare disease like Rett syndrome affects your family, it can feel like entering a world with more questions than answers. That’s where advocacy steps in. Advocates help bridge the knowledge gap between cutting-edge science and the day-to-day reality of living with a rare condition. They make complex medical information understandable, guide parents through the maze of possible interventions, and connect families to support networks and clinical research opportunities.
The experiences of families like Victor’s offer valuable context for researchers and pharmaceutical companies working on treatments. They shine a light on the most urgent unmet needs, whether it’s better communication aids, more inclusive clinical trials, or faster diagnosis. This feedback loop shapes the future of care and facilitates the development of meaningful, patient-centered therapies.
When advocates and scientists work hand-in-hand, it speeds up progress that might otherwise take years. It ensures research is not only about the disease, but about the people behind it.
Why It Matters
Behind every sequencing run and research publication, there’s a family navigating the unknown. Understanding Rett syndrome is more than identifying a genetic mutation. It’s about listening to those living with it and empowering them as partners in research and care.
When families feel informed and supported, they are better equipped to advocate for their children’s needs at school, in healthcare settings, and within their communities. Access to clear, understandable educational materials can help parents and caregivers communicate effectively with healthcare providers, contribute meaningfully to care decisions, and even participate in clinical trials and research studies that could shape future treatments.
Advocacy also builds community. When families connect with others experiencing the same journey, it reduces isolation and creates opportunities for collective action. These connections lay the foundation for stronger support networks, better funding for research, and accelerated therapeutic development.
Ultimately, advocacy humanizes science. It reminds us that rare diseases may be statistically uncommon, but that their impact on each individual’s life is profound. Advocacy ensures that people living with rare diseases like Rett syndrome are seen, heard, and included not just as patients but as vital contributors to the progress that can change lives.
